Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Introduction: Lymphocytes play pivotal roles in disease pathogenesis and can be used as potential biomarkers for various immunological conditions. Yet, current flow cytometry methods used in clinical settings are often only capable of measuring between four to eight distinct lymphocyte populations. The purpose of our study was to measure many lymphocyte and monocyte populations from a single sample, with the long-term aim of validating our assay for diagnostic use in the Australian regulatory environment.
Methods: We designed and optimised a novel 30-colour lymphocyte immunophenotyping panel tailored for use on a 3-laser (V-B-R) spectral flow cytometer. This panel measures over 50 lymphocyte and monocyte populations.
Results: In this report we present data derived from 148 healthy individuals.
Discussion: This lays the groundwork for future clinical application of spectral flow cytometry tests and offers a more comprehensive approach to lymphocyte and monocyte analysis with future implications for disease diagnosis and monitoring.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12322900 | PMC |
| http://dx.doi.org/10.3389/fimmu.2025.1577206 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Factors affecting hematological parameters in Creole goats on the Southern Coast of Peru.
Vet World
July 2025
Estación Experimental Agraria Chincha, Dirección de Servicios Estratégicos Agrarios, Instituto Nacional de Innovación Agraria (INIA), Ica 11770 Peru.
Background And Aim: Hematological parameters are critical indicators of health and physiological status in goats. This study aimed to evaluate the effects of location, feeding regimen, age, and body condition score (BCS) on hematological parameters in Creole goats reared under extensive systems on the southern coast of Peru and to establish context-specific reference values.
Materials And Methods: A total of 111 multiparous goats from nine herds were assessed.
Warfarin reduces circulating white blood cell count: Post-hoc analysis of two randomized trials.
Thromb Res
September 2025
Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg University, Mainz, Germany. Electronic address:
Warfarin is a widely used vitamin K antagonist (VKA) with known pleiotropic effects beyond anticoagulation. Preclinical and case-control evidence suggests that warfarin may affect hematopoiesis, but longitudinal human evidence is lacking. To explore this potential effect, we conducted a post-hoc analysis of participants in the Hokusai-VTE and ENGAGE AF-TIMI 48 trials, which randomized patients to warfarin or the direct oral anticoagulant edoxaban with routine laboratory testing at predefined follow-up visits.
View Article and Find Full Text PDFBackground: Based on the widespread use of the systemic immune-inflammation index (SII), neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and lymphocyte-monocyte ratio (LMR), markers, we aimed to calculate and compare the reference intervals (RIs) of these indices in adults, using both nonparametric method according to the Clinical and Laboratory Standards Institute's (CLSI) EP28-A3C:2010 guideline and refineR algorithm using a large dataset.
Methods: We analyzed data from 293,585 adults (18 - 65 years) retrospectively obtained from complete blood count results (using laboratory information system). The study involved a two-stage outlier exclusion process.
L-shaped association of systemic inflammation response index with rheumatoid arthritis in U.S. adults: Evidence from NHANES 1999 to 2020.
Medicine (Baltimore)
September 2025
Department of Orthopedics, Lhasa People's Hospital, Lhasa, China.
Rheumatoid arthritis (RA) is an autoimmune condition characterized by widespread and persistent inflammation. In this study, we sought to investigate the association between the systemic inflammation response index (SIRI) and the likelihood of RA occurrence among individuals in the United States. This study conducted a retrospective analysis using data collected from the National Health and Nutrition Examination Survey from 1999 to 2020.
View Article and Find Full Text PDFHematological Markers Predict Immune-Related Adverse Events in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Pembrolizumab.
Asia Pac J Clin Oncol
September 2025
Department of Otorhinolaryngology, Head and Neck Surgery, Kitasato University School of Medicine, Sagamihara, Japan.
Background: In patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN), the correlation between hematological markers and treatment outcomes has been established. However, their predictive role in the development of immune-related adverse events (irAEs) remains unclear.
Methods: We conducted a multicenter retrospective cohort study to evaluate whether pre-treatment hematological markers-including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), and the CRP-albumin-lymphocyte (CALLY) index-predict the development of irAEs in 147 patients with R/M SCCHN treated with pembrolizumab.